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Summary
Objectives
The aim of this review is to evaluate whether the DSM-5 con-
cept of mixed features “specifier” provides a definition that re-
flects the richness and multiplicity of this psychopathological 
picture pointing out the historical development, clinical concep-
tualisation and proposed therapeutic approach to mixed states. 
Methods
We review and discuss the recent evidence on the presence 
of mixed features during mania and depression and summarise 
findings on the conceptualisation of mixed states. Electronic 
searches of all English-language papers were performed in the 
MEDLINE and PUBMED database using and cross-listing key 
words: mixed state, mixed features, bipolar disorder, major de-
pressive disorder, mania, hypomania, depression.
Results
The mixed categorical-dimensional concept used in the DSM-
5 broadens the concept of mixed episodes, introducing sub-
stantial changes to the diagnosis of mixed states. This definition 
appears more appropriate for less severe forms of mixed states 
presenting clear and detectable mood symptoms with evident 
improvement compared to the DSM-IV, as the possibility of clas-
sifying depression “with mixed features”.
Conclusion
The transition from the classical definition of mixed states to the one 
reported in the DSM-5 has determined a complex modification of 
the concept of mixed state. The DSM-IV-TR description, based on 
the co-presence of symptoms of opposite polarity, was extremely 
reductive and did not capture the sub-syndromal symptoms of the 
opposite pole experienced in bipolar and major depressive disor-
ders. The DSM-5 definition of mixed features “specifier” represents 
a valid tool to improve the recognition and proper treatment of 
bipolar mixed patients, reducing misdiagnosis and mistreatment 
associated with chronic and repetitive exposure to antidepressants 
and sedatives, although the mixed categorical-dimensional con-
cept does not adequately reflect some overlapping mood criteria, 
such as mood lability, irritability and psychomotor agitation.
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Introduction
Mixed affective states are largely considered the simulta-
neous occurrence of manic and depressive features with 
a complex clinical presentation that frequently represents 
a real challenge for clinicians due to the evident difficul-
ties in diagnosis, classification and treatment. The concept 
of mixed states introduced by Kraepelin was character-
ised by the presence of depressive and manic/hypomanic 
phases in manic-depressive patients and by the presence 
of a continuum between depressive and manic features. 
Though several authors had previously described the char-
acteristics of mixed states, Kraepelin firstly provided a con-
ceptualisation within a broader context, defining mixed 
states as the ‘third polarity’ of manic-depressive disorder 
and used this idea to consolidate his unified vision of this 
disorder. Through the years the concept of mixed states has 
been consolidated and the relevance of mixed states has 
been recognised, but the concept of a continuum between 
different affective states was excluded from the main psy-
chiatric diagnostic systems (DSM and ICD). The failure of 
the DSM-IV-TR and ICD-10 in recognising mixed states 
together with the result of several studies on the topic en-
couraged many clinicians and researchers to reconsider 
the criteria for mixed episodes. In the DSM-5, the mixed 
episode as defined in DSM-IV-TR has been removed and 
sub-threshold non-overlapping symptoms of opposite po-
larity are identified using a mixed feature specifier to be 
applied to depression, mania and hypomania. 
The history of the concept of mixed states
The first descriptions of a clinical condition that we cur-
rently would consider a mixed state appeared in the nine-
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Emil Kraepelin first used the term “mixed states” (Mis-
chzustände) (Table II) starting from the 5th edition of his 
Textbook of Psychiatry 4, and maintained this term in the 
revised editions of the text  5 6. He recognised as a sig-
nificant contribution to his categorisation the work of his 
apprentice Wilhelm Weygandt, author of a pioneering 
monograph on the subject, the first book in the psychi-
atric literature on mixed states. Weygandt first described 
three conditions under the term Mischzustände (Table I), 
and recognised that these mixed states had a favourable 
outcome compared to schizophrenia (Dementia Praecox) 
(“when we deal with manic stupor, agitated depression, 
and unproductive mania, we can foresee a highly favour-
able outcome”) 7. Kraepelin, however, first provided a con-
ceptualisation of mixed states within a broader context: he 
viewed mixed states as a ‘third polarity’ of manic-depres-
sive disorder, and used this idea to consolidate his unified 
vision of this disorder (The inner relationship of the appar-
ently opposing conditions becomes most clear through the 
experience that there are fits of circular insanity in which 
excitement and depression are mixing in an inextricable 
way)  6. The possible co-occurrence of symptoms in the 
manic and depressive phases, seemingly antithetical, in his 
view confirmed the common association of two polarities 
of the same underlying disease, supporting a hypothesis 
that had been around since ancient times. Kraepelin iden-
tified a total of six different basic types of mixed states, 
depending on the combination of alterations in the three 
different psychic domains that, in his and Weygandt opin-
ion, were involved in manic-depressive illness. The three 
domains consisted of mood (emotion), ideation (intellect, 
or thought) and motor activity (volition or psychomobil-
ity in Weygandt terminology). Each domain can fluctuate 
teenth century (Table I); however, traces of what is con-
sidered to be a “mixed state” are present in antique medi-
cal textbooks (especially Aretaeus of Cappadocia) and in 
some treatises on psychopathology in the 1700s 1. Hein-
roth, in his treatise entitled Disturbances of Mental Life or 
Mental Disturbances  2, was one of the first psychiatrists 
to explore mixed states in detail; he used a German term 
(Mischungen) translatable as “mix or mixture” to define 
psychopathological conditions in which discordant ele-
ments coexisted. Another German psychiatrist, Griesing-
er 3, described states of mental alteration in which mel-
ancholic and manic elements coexisted (as in Heinroth’s 
descriptions), as well as forms that would be currently 
defined as rapidly cycling affective disorders. He defined 
such psychopathological conditions as “mid-forms” (Mit-
telformen), “in which a change from depression to the 
manic exaltation occurs”, and described “Melancholia 
with destructive impulses” and “Melancholia with long-
lasting exaltations of volition”. In his view, then, mixed 
states could be often transitional forms.
In addition to the above authors, other European psychia-
trists before Kraepelin described psychopathological con-
ditions that had similarities to mixed states. For example, 
Jules Falret in 1861 described what he termed État Mixte, 
a condition characterized by “predominant ideas, often 
of sad nature, in the middle of an excitation state, simu-
lating true mania”. However, none of the cited authors 
provided a precise categorisation of psychopathological 
conditions in the manic-depressive area, including mixed 
states, which first appeared with the works of Wilhelm 
Weygandt and Emil Kraepelin. These two authors first 
conferred nosographic autonomy to mixed states in the 
context of Manic-Depressive Insanity.
Table I. 
The development of the concept of mixed states (before Kraepelin).
author Definition 
Heinroth, 1818 MISCHUNGEN (mixtures) – hypo/asthenias
Griesinger, 1845 MITTELFORMEN (middle forms) “in which a change from depression to the manic exaltation occurs”:
• melancholia with destructive drives
• melancholia with long-lasting exaltation of volition
Falret, 1861 ÉTAT MIXTE (mixed state)
“predominant ideas, often of sad nature, in the middle of an excitation state, simulating true mania”
Weygandt, 1899 MISCHZUSTÄNDE (mixed states):
• manic stupor (elevated mood with psychomotor inhibition and decreased ideation)
• agitated depression (depression with flight of ideas and agitation)
• unproductive mania (elated mood with increased motor activity and inhibition of thinking)
“When we deal with manic stupor, agitated depression, and unproductive mania, we can foresee a highly 
favourable outcome”
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infinite possibilities that a mixture of manic and depres-
sive elements could manifest in the same patient 8. In their 
opinion, apart from multiform phenomenal appearances, 
the essential point for diagnosis of a mixed state was the 
co-occurrence of manic and depressive elements/symp-
toms/signs in a patient with clinical features that reflected 
manic-depressive disorder, and in particular a previous 
history of manic and depressive episodes (according to 
Kraepelin, cyclicity – recurrent episodes – defines the ill-
ness, irrespective of polarity). 
Beyond the six subtypes of mixed states, Kraepelin dis-
tinguished between two general classes of mixed states: 
“transitional” forms, i.e. clinical pictures that frequently 
arise in the transition from mania to depression and vice 
versa (reflecting Giesinger’s vision of mixed states), and 
“autonomous” forms, i.e. those that appear and manifest 
as such (Table II). According to Kraepelin, these “autono-
mous” mixed states were the most unfavourable ones, 
presenting with a longer course and the tendency to be-
come chronic 9. 
The concept of Kraepelinian mixed states was the object 
of harsh criticism by other prominent European psychia-
trists: Karl Jaspers  10, for example, refused the concept 
of a mixed state from a methodological standpoint, and 
Kurt Schneider 11 negated the existence of this diagnostic 
category, viewing it as a simple transitional phase (from 
mania to depression and vice versa) in manic-depressive 
disorder. These are only two examples of the general lack 
of interest in mixed states that manifested after 1920s, 
defined by Marneros 9 as the “period of ignorance”, evi-
denced by the dramatic decrease in the number of publi-
cations on the subject.
One of the few exceptions was a monograph by the 
German psychiatrist Mentzos, who utilised some con-
around baseline in two directions: overall increase and 
decrease, giving rise to 2 states characterised by all 3 do-
mains being in the same phase (classic mania and depres-
sion), and 6 mixed states, uniquely defined by asynchro-
nous phase shifting of the 3 domains. Thus, he described 
the different mixed states of a) “manic depression or anxi-
ety” (depressed mood, flight of ideas and hyperactivity), 
b) “excited depression” (depressed mood, inhibition of 
thought and hyperactivity), c) “unproductive mania” (eu-
phoria, inhibition of thought and hyperactivity), d) “manic 
stupor” (euphoria, inhibition of thought and apathy), e) 
“depression with flight of ideas” (depressed mood, flight of 
ideas and apathy) and f) “inhibited mania” (euphoria, flight 
of ideas and apathy) (Table III). 
The subsequent revisions of Kraepelin and Weygandt of 
the concept of mixed states partially overcame this tri-
partite model of the psyche, favouring a dimensional ap-
proach that involved a broadening of the concept to the 
Table II. 
Kraepelinian view of mixed states.
Kraepelin, 1893-1913
Tripartite model:
1. affect
2. psychomotor activity
3. associative processes
MISCHZUSTÄNDE (mixed states) 
or 
MISCHLFORMEN (mixed forms): 
6 types
Two general classes 
of mixed states
1. Transitional forms: a stage 
2. in between, when depression 
changes to mania and vice versa
3. Autonomous forms: mixed 
disorder on its own
Table III. 
Kraepelinian Mixed States (1913).
Mood Motor activity Ideation
1. Depressive or anxious mania
(depressive oder angstliche Manie)
- + +
2. Excited depression 
(erregte Depression)
- + -
3. Unproductive mania or Mania with thought poverty
(ideenarme Manie)
+ + -
4. Manic stupor
(manischer Stupor)
+ - -
5. Depression with flight of ideas
(ideenfluchtige Depression)
- - +
6. Inhibited mania
(gehemmte Manie)
+ - +
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of the 1980s, the initial stages of which can be seen in 
the “Vienna Criteria” 13, named after the city from which 
the authors originated. The Vienna School, in the wake 
of Mentzos, divided mixed states into two subtypes, sta-
ble and unstable, and proposed precise diagnostic crite-
ria for the identification of both (Table IV). These criteria 
were based on a well-defined psychopathological model 
known as Janzarik’s concept of structural-dynamic coher-
ence  14. According to this model, similar to the idea of 
Mentzos, mixed states were perceived as the product of 
unstable alteration of the “dynamic”. The term dynamic 
referred to the mixture of two components that normally 
form the individual’s personality: one that constitutes the 
functional substrate of the temperament and a “structur-
al” form that encodes both innate and acquired behav-
ioural patterns. A strict adherence to this model, which 
is provocative and challenging, limited the use of the 
Vienna Criteria to research purposes. Nonetheless, these 
criteria represented a turning point that influenced and 
stimulated research in the forthcoming years, giving rise 
to a large number of publications, especially in the US 
and Europe. Among these, Akiskal in the US and Kouko-
poulos in Italy, greatly contributed to the so-called renais-
sance or revival of mixed states 15. Akiskal postulated that 
mixed states are not a mere overlap of depressive and 
manic opposite symptoms, but rather that they arise from 
the combination of an affective episode with a domi-
nant temperament of opposite polarity; mixed states may 
arise: 1. when a temperament intrudes into an affective 
cepts from Weygandt and proposed a new classifi-
cation of mixed states. Building upon the static con-
ception and clinical descriptions of Kraepelin and 
Weygandt, Mentzos added a dynamic view. In fact, the 
classification of Mentzos referred to a psychopatho-
logical model which was not based on the description 
of a clinical picture as a group of different symptoms; 
indeed, the mixed state was interpreted using the so-
called “mood boost” system. According to this view, 
mood alterations in bipolar disorder could be seen as 
pathological variations of the “boost”, or as the un-
derlying force behind psychic processes, and “mood” 
as the prevalent affective tone that “colours” thoughts 
of consciousness. In this model, mania and depression 
are seen as concordant alterations of boost and mood 
(increased energy and euphoric mood vs. decreased 
energy and depressed mood), while mixed states are 
viewed as discordant alterations (e.g. increased ener-
gy and depressed mood). Mentzos used a bipartition 
between “mixed states” where the deviations in boost 
and mood were discordant but stable, and “mixed pic-
tures”, where they were discordant and, importantly, 
variable over time (unstable). Unfortunately, due to 
the complexity of this psychopathologic model, clear 
criteria for the identification of mixed states were not 
proposed, and the terminology adopted was difficult to 
translate in the international nomenclature 12.
The revival of mixed states (what Marneros calls “the re-
naissance” of mixed states) started from the beginning 
Table IV. 
Vienna school criteria for stable and unstable mixed states (from Berner et al., 1983, modified).
Unstable mixed states
A. Appearance of at least one of the following rapidly cycling changes following a period of normal functioning:
1. mood changes rapidly cycling from depression and/or anxiety, euphoric/expansive hostile mood
2. rapid cycling and exaggerated emotional resonance in various affective states (depressive, anxiety, manic and hostile)
3. rapid cycling between inhibition, agitation, increase in drive and occasional aggressiveness
B. Biorhythmic disturbances*
1. diurnal variations of affectivity, emotional resonance, or drive
2. sleep disturbances (interrupted, prolonged, or shortened sleep or early awakening)
Stable mixed states
A. Appearance of persistent variations in affectivity, emotional resonance or drive after a period of normal functioning (requires 
symptoms 1 and/or 2 and 3):
1. depressed, anxious, euphoric/expansive or hostile mood
2. lack of emotional resonance or limited to depressive, manic, hostile or anxious response
3. persistent presence of drive in contrast with the affective status and/or emotional resonance
B. Appearance of biorhythmic disturbances*
1. daily changes in affectivity, emotional resonance, or drive
2. sleep disturbance (interrupted, prolonged, or shortened sleep or early awakening)
* Symptoms 1 and 2 are required.
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manic/hypomanic symptoms. Psychomotor agitation is 
required for the diagnosis of agitated depression. Com-
pared to non-mixed episodes, the symptomatology of 
mixed depressive episodes includes the presence of a 
greater irritability and mood lability associated with 
mental and psychomotor overactivity, restless agitation 
and increased suicidality 19. 
Mixed states in DSM-5 and ICD-10 
Both the American Psychiatric Association classifica-
tion system (the Diagnostic and Statistical Manual for 
Mental Disorders - DSM, now in its fifth edition) 20 and 
the World Health Organization (International Classifi-
cation of Diseases - ICD-10)  21 provide a definition of 
mixed states far from the richness and multiplicity of 
psychopathological descriptions reviewed in the previ-
ous paragraphs. The DSM classification, however, made 
significant changes in the description of mixed episode 
from DSM-IV-TR  22 to the new “with mixed features” 
specifier in DSM-5.
According to DSM-IV-TR criteria, it was only possible 
to diagnose a mixed episode if the criteria for both a 
manic and a major depressive episode (except duration 
– only one week was required) were met. In the ICD-10, 
the term “mixed episode” indicates the co-occurrence 
or rapid cycling of prominent depressive and manic or 
hypomanic symptoms for at least 2 weeks. The 11th re-
vision of the ICD will likely revise the concept of mixed 
episode following DSM revision. The two classification 
systems simplified the concept of “mixed states” and 
grouped them into a single diagnostic category (mixed 
episode); this simplification, however, brought about a 
series of problems, especially in terms of sensitivity in 
revealing psychopathologic symptoms that the majority 
of clinicians would judge as belonging to that category, 
but which do not reach sufficient threshold criteria to 
make a diagnosis.
Considering the DSM-IV-TR, the possibility that mixed 
states can coexist in the context of type II bipolar disorder 
was excluded, contrary to common experience in clinical 
practice. Moreover, the definition of mixed episode as the 
coexistence of full depressive and manic episodes meant 
that the presence of few symptoms of opposite polarity in 
the context of predominant manic or depressive episode 
was not considered. A third limitation of the DSM-IV-TR 
criteria for mixed episode was the exclusion criterion C: 
“the symptoms are not due to the direct physiological ef-
fects of a substance (e.g. a drug of abuse, a medication, 
or other treatment) or a general medical condition (e.g. 
hyperthyroidism)”; affective episodes temporally corre-
lated with the use of substances (drug of abuse, antide-
pressants, somatic therapies) and with prominent mixed 
features are, on the contrary, very common in clinical 
episode of opposite polarity (e.g., depressive tempera-
ment into mania or hyperthymic temperament into major 
depression), or 2. when the instability of a cyclothymic 
temperament transforms a major depression into a mixed 
picture  16. Koukopoulos, on the other side, contributed 
to the understanding of agitated depression as a mixed 
state, and challenged the notion of polarity as the basic 
criterion for bipolar disorder  17. He defined “mixed de-
pression” a depression occurring with excitation, mean-
ing manic symptoms (like flight of ideas or talkativeness), 
but also agitation, irritability and rage, marked anxiety 
and suicidal impulsivity. Koukopoulos considered this 
highly agitated and tense depressive state as the opposite 
of melancholia, which is markedly psychomotor retarded 
and not irritable or rageful. Unfortunately, Koukopoulos’ 
view was not fully endorsed in tge DSM-5. 
Mixed states in DSM-IV-TR 
Mixed Mania
In the scientific literature there is no univocal definition 
for mixed mania, also known as depression during ma-
nia or dysphoric mania, and the clinical presentation 
has been described in several different ways. The clas-
sic definition includes the presence of a complete manic 
syndrome together with the presence of at least three 
depressive symptoms, but, using a more unrestricted ap-
proach based on the presence of two depressive symp-
toms, the frequency of the diagnosis of mixed mania sig-
nificant increases. Compared to non-mixed episodes, the 
symptomatology of mixed manic episodes includes the 
presence of a greater mood lability and irritability, dys-
phoric mood, anxiety, suicidality and cognitive impair-
ment. On the other hand, these patients report less severe 
typical manic symptoms, such as euphoria, grandiosity, 
decreased need for sleep and involvement in pleasant ac-
tivities. Frequently, the most severe forms are character-
ised by the presence of psychotic symptoms, such as de-
lusions, hallucinations and motor disturbances that make 
it difficult to differentiate these forms from schizophrenia 
and other psychoses 18.
Mixed depression
In the same way, a consistent number of depressed pa-
tients show manic symptoms, without a clear, univocal 
definition for this condition called mixed depression, 
also known as agitated depression or dysphoric depres-
sion. The frequency of this form is variable ranging be-
tween 20 and 70%, and this wide fluctuation mainly 
depends on the different tools used for the assessment 
of affective symptomatology. The classic definition in-
cludes the presence of a complete depressive syndrome 
together with the presence of a minimum of two or three 
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epidemiology
The diagnosis of mixed affective states represents a chal-
lenge for clinicians for the different definitions and the 
frequency of mixed and non-mixed manic subtypes, 
which are mainly dependent on setting, interview meth-
ods, assessment and criteria adopted. This problem is the 
main cause of the differences of prevalence rates found in 
the different studies. Akiskal 26 stated that mixed states are 
a common presentation of BD, but a careful evaluation 
highlights large differences among mixed manic or de-
pressive states and a huge variability linked to the criteria 
used for the evaluation.
For mixed manic states, the prevalence rates are usually 
lower when adopting the ICD-10 and DSM-III/IV cri-
teria, ranging from 19% (ICD 10, 33) to 6.7-28%  27 28. 
Prevalence rates of mixed depressive states are somewhat 
scarce and the variability for manic mixed state is similar 
to that found for mixed depressive states. Indeed, across 
studies, the differences fluctuate between 20 and 70%, 
and the frequency of mixed and non-mixed depressed 
subtypes is mainly dependent on setting, interview meth-
ods, assessment and criteria used 29. Data on gender gen-
erally demonstrate the presence of differences between 
subtypes, confirming the presence of a female predomi-
nance in the mixed manic state ranging from 63 to 69% 
and the absence of gender differences in the prevalence 
of mixed depression 30.
Treatment 
The pharmacological treatment of mixed bipolar states 
remains a challenge for clinicians. Results from studies 
and clinical practice show that mixed presentations in bi-
polar disorder have a poorer pharmacological response 
compared with pure episodes, and combination therapy 
is often required 31 32. An additional challenge in the treat-
ment of mixed states arises from the need to concurrently 
treat both manic and depressive symptoms: depressive-
switch risk often may derive from an antipsychotic mono-
therapy centred on improving manic symptoms  33, par-
ticularly in the case of conventional antipsychotics and 
other drugs with a high polarity index 34. Conversely, anti-
depressants can induce a manic/mixed switch 35. The lack 
of standard definitions of mixed states, the low reliability 
of assessment measures and the DSM-IV-TR definition 
(considering mixed episodes as variants of mania) are fur-
ther potential reasons for the lack of adequate research 
in this area. The majority of data is derived from post-hoc 
analyses of studies including manic patients and from 
a handful number of double-blind, placebo-controlled 
studies  36. Combinations of atypical antipsychotics and 
conventional mood stabilisers, particularly divalproate, 
have the most consistent evidence 37.
practice and could not be correctly recognised and diag-
nosed according to DSM-IV-TR criteria 23.
The major limitations in ICD-10 criteria concern the low 
precision and reliability of the diagnostic definition itself, 
since the number of symptoms needed for the diagnosis 
is not specified. A second limitation of ICD-10 criteria is 
the poor sensitivity relative to temporal criteria: ICD-10 
requires a duration of two weeks, which is considered to 
be excessive 24. 
In the DSM-5, a revision was made on criteria for 
mixed episodes: the new criteria have replaced the 
category “mixed episode” (extremely narrow defini-
tion of mixed states) with the specifier “with mixed 
features” (broad definition). The new classification will 
capture subthreshold, non-overlapping symptoms of 
the opposite pole using the new “with mixed features” 
specifier to be applied to manic episodes in bipolar 
I disorder (BDI), hypomanic and depressive episodes 
experienced in BDI, BD type II and major depressive 
disorder. In the new mixed categorical-dimensional 
concept used in the DSM-5, the mixed features speci-
fier: 1) would apply not only to manic episodes (as in 
the DSM-IV), but also to hypomanic and major depres-
sive episodes (even in a MDD longitudinal diagnosis), 
and 2) broadens the concept of mixed episodes as the 
threshold for the diagnosis is lowered to ≥3 symptoms 
of opposite polarity. It is evident that these new criteria 
have introduced considerable changes to the diagnosis 
of mixed states, which are in agreement with many of 
the aforementioned studies.
The current DSM-5 definition replaced the diagnosis 
of “mixed episode” with a “mixed-features specifier” 
which should be applied to episodes of major depres-
sion, either hypomanic or manic, together with, or in 
close juxtaposition, with at least three symptoms of 
opposite polarity. The mixed features specifier may be 
considered when patients with manic or hypomanic 
symptoms show at least three depressive symptoms and, 
conversely, if a depressed patient shows manic or hy-
pomanic symptoms. Patients meeting criteria for mania 
and depression (the mixed episode of DSM-IV-TR) in the 
DSM-5 satisfy the criteria for “mania with mixed fea-
tures”, highlighting the greatest functional compromise 
and clinical severity of mania over depression 20.
The ICD-11 criteria will be substantially similar to those 
of the DSM-5, with the difference that the term “mixed 
episode” will be maintained and further divided into six 
subtypes depending on the current predominant episode 
and presence of psychotic symptoms 25. For example, the 
possible diagnoses will be “actual mixed episode, cur-
rent mania with depressive symptoms, psychotic (or non-
psychotic)”; a similar scheme will be used for hypomanic 
and depressive episodes. 
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as a type of mania. The DSM-5 has eliminated mixed epi-
sodes as a category, while including mixed features as a 
course specifier for both manic and depressive episodes. 
The results of this meta-analysis suggest that SGAs are 
clearly effective in treating manic symptoms in mixed 
episode patients with syndromal mania and syndromal 
depression. However, findings on depression are limited 
and further studies are needed to establish the efficacy of 
SGAs in treating depressive symptoms in manic patients 
with mixed features.
Ouanes et al. 49 in a recent review demonstrated the over-
all efficacy of SGAs in mixed episodes. Antidepressant 
use is perhaps the most controversial issue in the treat-
ment of bipolar disorder and the scientific literature is 
limited and controversial 50. Some studies support that the 
adjunctive use of antidepressants is not associated with 
an increased risk for switching to mania/hypomania or 
mixed episodes 51, but others are at odds with these find-
ings 52, showing that antidepressants do not significantly 
increase the rate of enduring recovery from depression in 
bipolar I and II disorder. Nevertheless, there is a substan-
tial consensus on avoiding antidepressant monotherapy 
in bipolar patients with mixed/cycling features or prior 
antidepressant-associated mania/hypomania  53. Interna-
tional guidelines give heterogeneous recommendation 
and take into consideration two potentially harmful ef-
fects of antidepressants, including the induction of hy-
pomania/mania or mixed episodes and rapid cycling. 
However, a consensus exists in stopping the ongoing an-
tidepressant medication during a mixed episode in both 
bipolar I and II patients 54.
Conclusions 
Bipolar disorder has been the subject of significant re-
visions in the DSM-5. One of these major changes has 
been the removal of BD from the ‘Mood Disorders’ sec-
tion and its inclusion in the new category of ‘Bipolar and 
Related Disorders’. Another significant change concerns 
mixed states: the diagnosis of “mixed episode” has been 
replaced with a “mixed-features specifier” which should 
be applied to episodes of major depression, either hypo-
manic or manic, together with, or in close juxtaposition, 
at least three symptoms of opposite polarity. The mixed 
features specifier may be considered when patients with 
manic or hypomanic symptoms show at least three de-
pressive symptoms and, conversely, when depressed 
patients show manic or hypomanic symptoms. Patients 
meeting criteria for mania and depression (the former 
mixed episode of DSM-IV-TR), will receive the DSM-5 
diagnosis of “mania with mixed features”, emphasising 
the greatest functional compromise and clinical severity 
of mania over depression.
Even if most second generation antipsychotics (SGAs) 
have been approved for the treatment of mania, only a 
few guidelines make specific recommendations for man-
aging mixed episodes, given the paucity of evidence-
based data 32. Available data show that asenapine, olan-
zapine and valproate have positive effects in patients 
with mixed mania in placebo-controlled trials  38-40, and 
aripiprazole and ziprasidone show separation from pla-
cebo in pooled analyses  41 42. There are a few positive 
data on the use of quetiapine in acute mixed states  43. 
Ziprasidone has been tested in depressive mixed states 44. 
Asenapine and olanzapine have shown positive effects in 
combination with valproate in patients with mixed ma-
nia. The guidelines of the World Federation of Societies 
of Biological Psychiatry  45 recommend lithium in pure 
euphoric mania rather than in mania with dysphoric or 
depressive symptoms, while carbamazepine is suggested 
for mixed states or dysphoric mania, and valproate for 
both manic/depressive dysphoric features during a manic 
episode. Among typical antipsychotics, haloperidol may 
exacerbate depressive and dysphoric symptoms in mixed 
mania. The guidelines of the British Association for Psy-
chopharmacology (BAP)  46 recommend oral administra-
tion of antipsychotics or valproate as first-line treatments 
for severe mixed episodes, in patients not already on 
long-term treatment. The CANMAT and ISBD treatment 
guidelines 40 suggest aripiprazole, paliperidone ER, olan-
zapine and asenapine monotherapy as first-line choice in 
mixed mania. The NICE guidelines suggest that patients 
with mixed states should be treated as if they have an 
acute manic episode, and no antidepressants should be 
prescribed. 
Data on the use of SGAs in the treatment of acute mixed 
episodes are limited, both in monotherapy and in com-
bination. In one randomised trial of a mixed episode co-
hort, Houston et al. 47 reported earlier reduction of both 
manic and depressive symptoms of mixed episodes in 
patients treated with adjunct olanzapine over a 6 week 
period compared to adjunct placebo. 
Muralidharan et al.  48 published the first meta-analysis 
of all randomised double-blind placebo-controlled clini-
cal trials on the efficacy of SGAs (as monotherapy or in 
combination with mood stabilisers) in treatment of mixed 
episodes, according to the DSM-IV criteria. The meta-
analysis showed that SGAs in combination with mood 
stabiliser were superior to placebo plus mood stabiliser. 
The authors specified that SGAs were superior to place-
bo in the treatment of mixed episodes, particularly for 
manic symptoms, while moderately effective in reducing 
depressive mixed symptoms. Nonetheless, the interpreta-
tion of results should take into consideration that clinical 
trials included patients experiencing mixed episodes as 
defined in the DSM-IV, which considers mixed episodes 
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The revival of the concept of mixed states will be hopeful-
ly fostered by changes in the DSM-5 definition, and is also 
a consequence of the renewed interest on this subtype of 
bipolar disorder. Of course, the current criteria of mixed 
states are not equivalent to the classical, Kraepelinian no-
tion of mixed states and could have been improved. Both 
DSM-IV-TR definition of mixed states and the DSM-5 
mixed features specifier show clear troubles, in particular 
in recognising severe mixed states, while the combina-
tory model shows a greater sensitivity for the definition 
of less severe varieties of mixed states characterised by 
clearly identifiable symptoms. Moreover, the mixed cate-
gorical-dimensional concept used in the DSM-5 does not 
adequately reflect some overlapping mood criteria, such 
as mood lability, irritability and psychomotor agitation, 
considered among the most common features of mixed 
depression. The significant changes made in the DSM-5 
will help researchers in studying the clinical characteris-
tics of this subtype of bipolar disorder and in implement-
ing effective treatment strategies. Guidelines for the treat-
ment of mixed states, in fact, do not give clear indications 
for pharmacological or non-pharmacological treatments 
of mixed states, and the few available data are limited to 
post-hoc analyses and subanalyses performed in bipolar, 
mostly manic, patients.
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